Table 2.

Adjusted odds of virologic success for patient, disease, and treatment-related predictors

	Adjusted OR for virologic success‡ [95% CI]	p-value
CB care [n = 178] (vs. HB [n=237])	1.24 [0.69–2.33]
Patient characteristics
Age ≥ 50 years	1.22 [0.61–2.44]	0.57
Male gender	1.18 [0.64–2.19]	0.60
Ethnicity
African-American	1.54 [0.44–5.41]	0.50
Latino	1.19 [0.33–4.33]	0.79
HIV risk factor
IDU	1.73 [0.76–3.91]	0.19
Current illicit substance use	0.96 [0.50–1.84]	0.89
≥ 95% cART adherence	21.5 [11.4–40.6]	< 0.01
Disease characteristics
HIV diagnosis ≥ 5 years	0.78 [0.34–1.80]	0.57
Pre-treatment CD4 > 200 cells/mm3	1.13 [0.60–2.14]	0.71
Pre-treatment VL > 100k copies/mL	0.47 [0.24–0.93]	0.03
Treatment characteristics
Current/ever antiretroviral use	0.48 [0.20–1.17]	0.11
NNRTI-based regimen	1.59 [0.81–3.11]	0.18
Visit frequency (vs. 1–3 visits/year)
4–5 visits/year	1.56 [0.65–3.75]	0.32
≥ 6 visits/year	2.89 [1.22–6.84]	0.02

Note:

^‡including adjustment for propensity score

[abbreviations: CB = community-based; HB = hospital-based; NNRTI = non-nucleoside reverse transcriptase inhibitor]